Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.05% | -21.07% | -28.64% | -46.48% | -63.50% |
| Total Depreciation and Amortization | -20.73% | -30.52% | -25.64% | -18.63% | 9.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.97% | 29.66% | 28.06% | 40.28% | 58.44% |
| Change in Net Operating Assets | -113.06% | -207.55% | -156.09% | -92.58% | 13,212.90% |
| Cash from Operations | -36.44% | -38.18% | -52.85% | -69.80% | -46.36% |
| Capital Expenditure | -- | -- | 45.48% | 69.17% | 79.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | 300.00% | -500.02% | -300.14% |
| Cash from Investing | 100.00% | 6,591.72% | 310.71% | -508.92% | -307.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 6.06% | -673.73% | -113.15% | -- | -- |
| Issuance of Common Stock | 58.55% | -- | 94.42% | -- | 25,328.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 60.63% | 4,677.36% | 90.58% | -1,235.21% | 24,536.68% |
| Foreign Exchange rate Adjustments | -122.58% | -285.71% | 60.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 687.01% | 204.73% | 442.70% | -966.91% | 315.12% |